These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25858663)

  • 41. Treatment of chronic HCV genotype 1 coinfection.
    Boesecke C; Rockstroh JK
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):326-35. PubMed ID: 26228050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES.
    Chen JY; Ren Y; Yan P; Belina ME; Chung RT; Butt AA
    J Viral Hepat; 2018 Jul; 25(7):825-833. PubMed ID: 29478294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
    Younossi ZM; Stepanova M; Sulkowski M; Naggie S; Puoti M; Orkin C; Hunt SL
    J Infect Dis; 2015 Aug; 212(3):367-77. PubMed ID: 25583164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.
    Neukam K; Morano-Amado LE; Rivero-Juárez A; Mancebo M; Granados R; Téllez F; Collado A; Ríos MJ; de Los Santos-Gil I; Reus-Bañuls S; Vera-Méndez F; Geijo-Martínez P; Montero-Alonso M; Suárez-Santamaría M; Pineda JA
    HIV Clin Trials; 2017 May; 18(3):126-134. PubMed ID: 28599618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evolution of T-cell responses to hepatitis C virus (HCV) during pegylated interferon plus ribavirin treatment in HCV-monoinfected and in HCV/HIV-coinfected patients.
    Capa L; Soriano V; García-Samaniego J; Nuñez M; Romero M; de Mendoza C; Cascajero A; Muñoz F; González-Lahoz J; Benito JM
    Antivir Ther; 2007; 12(4):459-68. PubMed ID: 17668554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholesterol Levels in HIV- and/or HCV-Infected Drug Users Living in Argentina.
    Kohli R; Winston D; Sheehan H; Muzzio E; Benetucci J; Weissenbacher M; Wanke C; Knox T; Tang A
    J Int Assoc Provid AIDS Care; 2016 Sep; 15(5):400-5. PubMed ID: 26518591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kidney diseases in HIV/HCV-co-infected patients.
    Izzedine H; Sene D; Cacoub P; Jansen H; Camous L; Brocheriou I; Bourry E; Deray G
    AIDS; 2009 Jun; 23(10):1219-26. PubMed ID: 19440143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
    Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
    J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
    Mena A; Meijide H; Rodríguez-Osorio I; Castro A; Poveda E
    HIV Med; 2017 Oct; 18(9):685-689. PubMed ID: 28230318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comorbidities and their impact on mortality in HCV and HCV-HIV-coinfected persons on dialysis.
    Butt AA; Khan UA; Skanderson M
    J Clin Gastroenterol; 2008 Oct; 42(9):1054-59. PubMed ID: 19013829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.
    Rossi C; Cox J; Cooper C; Martel-Laferrière V; Walmsley S; Gill J; Sapir-Pichhadze R; Moodie EE; Klein MB;
    AIDS; 2016 Jun; 30(9):1403-311. PubMed ID: 26859371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01).
    Ingiliz P; Christensen S; Kimhofer T; Hueppe D; Lutz T; Schewe K; Busch H; Schmutz G; Wehmeyer MH; Boesecke C; Simon KG; Berger F; Rockstroh JK; Schulze zur Wiesch J; Baumgarten A; Mauss S
    Clin Infect Dis; 2016 Nov; 63(10):1320-1324. PubMed ID: 27535952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status.
    van Santen DK; van der Helm JJ; Grady BP; de Vos AS; Kretzschmar ME; Stolte IG; Prins M
    AIDS; 2014 Nov; 28(17):2589-99. PubMed ID: 25211439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.
    Byrne DD; Tate JP; Forde KA; Lim JK; Goetz MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Bedimo R; Freiberg MS; Justice AC; Kostman JR; Roy JA; Lo Re V
    Clin Infect Dis; 2017 Oct; 65(9):1542-1550. PubMed ID: 29020184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy.
    Bräu N
    AIDS; 2003 Nov; 17(16):2279-90. PubMed ID: 14571179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.
    Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R
    Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.
    Castells L; Rimola A; Manzardo C; Valdivieso A; Montero JL; Barcena R; Abradelo M; Xiol X; Aguilera V; Salcedo M; Rodriguez M; Bernal C; Suarez F; Antela A; Olivares S; Del Campo S; Laguno M; Fernandez JR; de la Rosa G; Agüero F; Perez I; González-García J; Esteban-Mur JI; Miro JM;
    J Hepatol; 2015 Jan; 62(1):92-100. PubMed ID: 25127748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.
    Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Carrieri P; Neau D; Morlat P; Marchou B; Dabis F; Salmon D;
    HIV Med; 2013 Aug; 14(7):430-6. PubMed ID: 23461846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.